View in EDS

Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.

Saved in:
Bibliographic Details
Title: Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.
Authors: Redondo-Muñoz M; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain., Rodriguez-Baena FJ; Instituto de Neurociencias, CSIC-UMH, Sant Joan d'Alacant, Spain., Aldaz P; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain., Caballé-Mestres A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Moncho-Amor V; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.; CIBER de Fragilidad y Envejecimiento Saludable (CIBERfes), Madrid, Spain., Otaegi-Ugartemendia M; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain., Carrasco-Garcia E; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.; CIBER de Fragilidad y Envejecimiento Saludable (CIBERfes), Madrid, Spain., Olias-Arjona A; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain., Lasheras-Otero I; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain., Santamaria E; Hepatology Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain., Bocanegra A; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain., Chocarro L; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain., Grier A; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Dzieciatkowska M M; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Bigas C; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Martin J; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Urdiroz-Urricelqui U; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Marzo F; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain., Santamaria E; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Clinical Neuroproteomics Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain., Kochan G; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain., Escors D; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain., Larrayoz IM; Biomarkers and Molecular Signaling Group, Center for Biomedical Research of La Rioja (CIBIR), Foundation Rioja Salud, Logroño, Spain.; Unidad Predepartamental de Enfermería, Universidad de La Rioja (UR), Logroño, Spain., Heyn H; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., D'Alessandro A; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain., Attolini CS; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Matheu A; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain., Wellbrock C; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Department of Health Sciences, Universidad Pública de Navarra (UPNA), Pamplona, Spain., Benitah SA; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. salvador.aznar-benitah@irbbarcelona.org.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. salvador.aznar-benitah@irbbarcelona.org., Sanchez-Laorden B; Instituto de Neurociencias, CSIC-UMH, Sant Joan d'Alacant, Spain. berta.lopez@umh.es., Arozarena I; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain. iarozarm@navarra.es.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain. iarozarm@navarra.es.
Source: Nature metabolism [Nat Metab] 2023 Sep; Vol. 5 (9), pp. 1544-1562. Date of Electronic Publication: 2023 Aug 10.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Nature Country of Publication: Germany NLM ID: 101736592 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2522-5812 (Electronic) Linking ISSN: 25225812 NLM ISO Abbreviation: Nat Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37563469
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Redondo-Muñoz+M%22">Redondo-Muñoz M</searchLink>; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Baena+FJ%22">Rodriguez-Baena FJ</searchLink>; Instituto de Neurociencias, CSIC-UMH, Sant Joan d'Alacant, Spain.<br /><searchLink fieldCode="AU" term="%22Aldaz+P%22">Aldaz P</searchLink>; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Caballé-Mestres+A%22">Caballé-Mestres A</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Moncho-Amor+V%22">Moncho-Amor V</searchLink>; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.; CIBER de Fragilidad y Envejecimiento Saludable (CIBERfes), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Otaegi-Ugartemendia+M%22">Otaegi-Ugartemendia M</searchLink>; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.<br /><searchLink fieldCode="AU" term="%22Carrasco-Garcia+E%22">Carrasco-Garcia E</searchLink>; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.; CIBER de Fragilidad y Envejecimiento Saludable (CIBERfes), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Olias-Arjona+A%22">Olias-Arjona A</searchLink>; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Lasheras-Otero+I%22">Lasheras-Otero I</searchLink>; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Santamaria+E%22">Santamaria E</searchLink>; Hepatology Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bocanegra+A%22">Bocanegra A</searchLink>; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Chocarro+L%22">Chocarro L</searchLink>; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Grier+A%22">Grier A</searchLink>; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Dzieciatkowska+M+M%22">Dzieciatkowska M M</searchLink>; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Bigas+C%22">Bigas C</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Martin+J%22">Martin J</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Urdiroz-Urricelqui+U%22">Urdiroz-Urricelqui U</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Marzo+F%22">Marzo F</searchLink>; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Santamaria+E%22">Santamaria E</searchLink>; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Clinical Neuroproteomics Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Kochan+G%22">Kochan G</searchLink>; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Escors+D%22">Escors D</searchLink>; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Larrayoz+IM%22">Larrayoz IM</searchLink>; Biomarkers and Molecular Signaling Group, Center for Biomedical Research of La Rioja (CIBIR), Foundation Rioja Salud, Logroño, Spain.; Unidad Predepartamental de Enfermería, Universidad de La Rioja (UR), Logroño, Spain.<br /><searchLink fieldCode="AU" term="%22Heyn+H%22">Heyn H</searchLink>; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22D'Alessandro+A%22">D'Alessandro A</searchLink>; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Attolini+CS%22">Attolini CS</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Matheu+A%22">Matheu A</searchLink>; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.<br /><searchLink fieldCode="AU" term="%22Wellbrock+C%22">Wellbrock C</searchLink>; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Department of Health Sciences, Universidad Pública de Navarra (UPNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Benitah+SA%22">Benitah SA</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. salvador.aznar-benitah@irbbarcelona.org.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. salvador.aznar-benitah@irbbarcelona.org.<br /><searchLink fieldCode="AU" term="%22Sanchez-Laorden+B%22">Sanchez-Laorden B</searchLink>; Instituto de Neurociencias, CSIC-UMH, Sant Joan d'Alacant, Spain. berta.lopez@umh.es.<br /><searchLink fieldCode="AU" term="%22Arozarena+I%22">Arozarena I</searchLink>; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain. iarozarm@navarra.es.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain. iarozarm@navarra.es.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101736592%22">Nature metabolism</searchLink> [Nat Metab] 2023 Sep; Vol. 5 (9), pp. 1544-1562. <i>Date of Electronic Publication: </i>2023 Aug 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101736592 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2522-5812 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225225812%22">25225812 </searchLink><i>NLM ISO Abbreviation: </i>Nat Metab <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37563469
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s42255-023-00861-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1544
    Titles:
      – TitleFull: Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Redondo-Muñoz M
      – PersonEntity:
          Name:
            NameFull: Rodriguez-Baena FJ
      – PersonEntity:
          Name:
            NameFull: Aldaz P
      – PersonEntity:
          Name:
            NameFull: Caballé-Mestres A
      – PersonEntity:
          Name:
            NameFull: Moncho-Amor V
      – PersonEntity:
          Name:
            NameFull: Otaegi-Ugartemendia M
      – PersonEntity:
          Name:
            NameFull: Carrasco-Garcia E
      – PersonEntity:
          Name:
            NameFull: Olias-Arjona A
      – PersonEntity:
          Name:
            NameFull: Lasheras-Otero I
      – PersonEntity:
          Name:
            NameFull: Santamaria E
      – PersonEntity:
          Name:
            NameFull: Bocanegra A
      – PersonEntity:
          Name:
            NameFull: Chocarro L
      – PersonEntity:
          Name:
            NameFull: Grier A
      – PersonEntity:
          Name:
            NameFull: Dzieciatkowska M M
      – PersonEntity:
          Name:
            NameFull: Bigas C
      – PersonEntity:
          Name:
            NameFull: Martin J
      – PersonEntity:
          Name:
            NameFull: Urdiroz-Urricelqui U
      – PersonEntity:
          Name:
            NameFull: Marzo F
      – PersonEntity:
          Name:
            NameFull: Santamaria E
      – PersonEntity:
          Name:
            NameFull: Kochan G
      – PersonEntity:
          Name:
            NameFull: Escors D
      – PersonEntity:
          Name:
            NameFull: Larrayoz IM
      – PersonEntity:
          Name:
            NameFull: Heyn H
      – PersonEntity:
          Name:
            NameFull: D'Alessandro A
      – PersonEntity:
          Name:
            NameFull: Attolini CS
      – PersonEntity:
          Name:
            NameFull: Matheu A
      – PersonEntity:
          Name:
            NameFull: Wellbrock C
      – PersonEntity:
          Name:
            NameFull: Benitah SA
      – PersonEntity:
          Name:
            NameFull: Sanchez-Laorden B
      – PersonEntity:
          Name:
            NameFull: Arozarena I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2023 Sep
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2522-5812
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Nature metabolism
              Type: main
ResultId 1